Clinical Trials Browser

Active not recruiting × OTHER × enfortumab vedotin × Clear all

NCT05923190 2026-03-19

Enfortumab Vedotin Schedule De-escalation in Metastatic Urothelial Carcinoma

Phase 2 Active not recruiting

Carcinoma, Transitional Cell

NCT04754191 2026-02-12

ENCORE

Phase 2 Active not recruiting

Metastatic Castration-resistant Prostate Cancer

NCT05915351 2025-04-16

Enfortumab Vedotin in Previously Treated Locally Advanced or Metastatic Pancreatic Cancer (EPIC)

Phase 2 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms